Literature DB >> 10687322

Is the presence of dyspnea a risk factor for morbidity in cancer patients?

P Edmonds1, I Higginson, D Altmann, G Sen-Gupta, M McDonnell.   

Abstract

Data collected from six home palliative care teams in Ireland were analyzed to determine the prevalence of dyspnea in the population studied and to identify factors associated with the presence of dyspnea that might impact on future care. The prevalence of mild, moderate, or severe dyspnea, as measured by the Support Team Assessment Schedule (STAS), fell from 39% at referral in 327 evaluable patients to 23%. The presence of dyspnea at referral was positively correlated with severity of patient spiritual distress (Spearman rho = 0.110, P = 0.042) and weakness (Spearman rho = 0.105, P = 0.008) at referral. In analysis of contingency tables, dyspnea was also significantly associated with low patient (chi 2 9.5, P = 0.002) and family (chi 2 50.78, P < 0.001) well-being, high staff anxiety (chi 2 4.14, P = 0.04), male sex (chi 2 8.9, P = 0.003), a diagnosis of lung cancer (chi 2 59.88, P < 0.001), and dying in hospital rather than hospice or nursing home (chi 2 18.03, P = 0.001). In adjusting for covariates using a logistic regression analysis, however, only the presence of low family well-being, a diagnosis of lung cancer, and increased likelihood of a hospital death remained significantly associated with the presence of dyspnea at referral. These data suggest that the presence of dyspnea may be associated with increased family distress, which may influence place of death.

Entities:  

Mesh:

Year:  2000        PMID: 10687322     DOI: 10.1016/s0885-3924(99)00145-1

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  8 in total

1.  Routine dyspnea assessment on unit admission.

Authors:  Kathy Baker; Jennifer Barsamian; Danielle Leone; Barbara C Donovan; Donna Williams; Kerry Carnevale; Robert Lansing; Robert Banzett
Journal:  Am J Nurs       Date:  2013-11       Impact factor: 2.220

2.  The Trajectory of Dyspnea in Hospitalized Patients.

Authors:  Ernest DiNino; Mihaela S Stefan; Aruna Priya; Benjamin Martin; Penelope S Pekow; Peter K Lindenauer
Journal:  J Pain Symptom Manage       Date:  2015-11-24       Impact factor: 3.612

Review 3.  Dyspnea review for the palliative care professional: assessment, burdens, and etiologies.

Authors:  Arif H Kamal; Jennifer M Maguire; Jane L Wheeler; David C Currow; Amy P Abernethy
Journal:  J Palliat Med       Date:  2011-09-06       Impact factor: 2.947

4.  Dyspnoea at rest predictor of increased in-hospital mortality in metastatic cancer patients undergoing emergent surgery in United States.

Authors:  Elleana J Majdinasab; Yana Puckett
Journal:  Ecancermedicalscience       Date:  2020-09-24

Review 5.  Management of Refractory Breathlessness: a Review for General Internists.

Authors:  Annie Massart; Daniel P Hunt
Journal:  J Gen Intern Med       Date:  2021-01-19       Impact factor: 5.128

6.  Management of the respiratory distress symptom cluster in lung cancer: a randomised controlled feasibility trial.

Authors:  Janelle Yorke; Mari Lloyd-Williams; Jacky Smith; Fiona Blackhall; Amelie Harle; June Warden; Jackie Ellis; Mark Pilling; Jemma Haines; Karen Luker; Alex Molassiotis
Journal:  Support Care Cancer       Date:  2015-06-26       Impact factor: 3.603

7.  Who experiences higher and increasing breathlessness in advanced cancer? The longitudinal EPCCS Study.

Authors:  M Ekström; M J Johnson; L Schiöler; S Kaasa; M J Hjermstad; D C Currow
Journal:  Support Care Cancer       Date:  2016-04-09       Impact factor: 3.603

8.  A randomised controlled trial of three or one breathing technique training sessions for breathlessness in people with malignant lung disease.

Authors:  Miriam J Johnson; Mona Kanaan; Gerry Richardson; Samantha Nabb; David Torgerson; Anne English; Rachael Barton; Sara Booth
Journal:  BMC Med       Date:  2015-09-07       Impact factor: 8.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.